Robbins writes, “He digs deep into the science to take down companies that he believes overhype their drugs, distort their data, or make ridiculously grandiose promises.
“And then he takes to Twitter to have a little fun. Feuerstein has called biotech CEOs ‘dumbass,’ ‘douche canoe,’ and ‘stem-cell smoothie peddler.’ He has referred to financial analysts as ‘moron’ and ‘dipshit.’ In his telling, several companies making bold claims were peddling nothing more than ‘diluted bleach water.’ A top public relations exec was a ‘human oil slick.’ AnotherPR firm? ‘Idiots.’ And those are just the insults we can print.
“‘I have an itchy trigger finger on hypocrisy,’ Feuerstein told STAT over beer at Lord Hobo, his favorite bar here, a stone’s throw from the biotech hub of Kendall Square.
“His stories make waves: Galena Biopharma fired its CEO after Feuerstein reported that the company had paid outside firms to promote its stock while insiders made millions selling it.”
Read more here.
Financial Times reporter Simon Foy is now covering European banks. He has been covering accounting for the…
Debtwire, the leading provider of global fixed income news, analysis and data for more than…
Amber Kanwar, an anchor for BNN Bloomberg in Canada, is departing at the end of…
Moody's Ratings has promoted Yvette Kantrow to senior vice president and editor in chief. She has been…
Politico reporter Clare Fieseler is leaving the news organization to take on some ocean reporting projects. She…
Wall Street Journal reporter Ben Eisen has signed a contract with Norton to write a book about…